Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Mental Health

Treatment of seasonal affective disorders

Data from randomized, controlled trials suggest that antidepressants are effective in the treatment of SAD.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors review how seasonal affective disorder is treated, noting that bright light therapy of at least 2500 lux is recommended as first-line, with morning dosing reported as superior to evening. They report response rates of about 80% in selected patients and cite three placebo-controlled trials of antidepressants, including sertraline, fluoxetine and moclobemide. The abstract states that the eye-only mechanism of light therapy has not been verified.

Who or what was studied
Patients with seasonal affective disorder, a subform of major depressive disorder, recurrent, or bipolar disorder with a seasonal pattern of depressive episodes
Limits stated in the abstract
The abstract does not report a sample size and states that the assumption that light therapy acts only through the eyes has not yet been verified.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Bright light therapy, Placebo-controlled, Lux. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies